Mesa Laboratories Inc (MLAB)
Cash conversion cycle
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | — | 105.14 | 114.73 | 124.29 | 134.89 | 158.23 | 142.14 | 151.38 | 148.08 | 141.93 | 112.08 | 120.14 | 119.36 | 133.80 | 84.80 | 88.44 | 86.27 | 87.99 | 81.38 | 89.55 |
Days of sales outstanding (DSO) | days | 63.57 | 59.33 | 64.30 | 58.03 | 65.94 | 61.77 | 62.07 | 59.25 | 70.89 | 69.59 | 68.50 | 76.41 | 81.63 | 83.29 | 57.82 | 54.07 | 64.82 | 57.23 | 53.07 | 53.93 |
Number of days of payables | days | — | 15.28 | 23.10 | 22.14 | 24.94 | 20.03 | 20.79 | 23.79 | 26.22 | 26.45 | 30.93 | 33.78 | 38.31 | 44.15 | 31.23 | 29.51 | 34.52 | 27.58 | 12.73 | 19.52 |
Cash conversion cycle | days | 63.57 | 149.19 | 155.93 | 160.18 | 175.89 | 199.97 | 183.42 | 186.84 | 192.75 | 185.07 | 149.65 | 162.76 | 162.68 | 172.93 | 111.38 | 112.99 | 116.57 | 117.63 | 121.72 | 123.96 |
March 31, 2025 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= — + 63.57 – —
= 63.57
The cash conversion cycle of Mesa Laboratories Inc has shown fluctuation over the years based on the provided data. The cash conversion cycle is a measure of the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales.
From June 30, 2020, to December 31, 2021, the trend was generally decreasing, indicating an improvement in the efficiency of Mesa Laboratories' working capital management. However, there was a significant increase in the cash conversion cycle from December 31, 2021, to March 31, 2022, followed by fluctuations until March 31, 2025.
The company's cash conversion cycle peaked at 199.97 days on December 31, 2023, and decreased significantly to 63.57 days by March 31, 2025, indicating a more efficient management of the company's working capital during that period.
Overall, Mesa Laboratories Inc should aim to maintain a lower cash conversion cycle to improve liquidity, optimize working capital management, and enhance overall financial performance. Fluctuations in the cash conversion cycle should be monitored to identify any potential inefficiencies in the company's operations that may require attention.
Peer comparison
Mar 31, 2025